Literature DB >> 12473267

IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver.

Katsumitsu Arai1, Zhang Xu Liu, Thomas Lane, Gunther Dennert.   

Abstract

Viral infection of the liver causes accumulation of T cells in the infected organ, raising the question as to the signals that mediate this response. Employing an adenovirus induced hepatitis model in mice, we show that IP-10 and Mig are essential for T cell recruitment and that induction of the two chemokines occurs concomitant to production of IFNgamma. It is shown that while IFNgamma induces IP-10 and Mig in hepatocytes, for optimal chemokine induction, a co-stimulatory signal mediated by cross-linking of Fas on hepatocytes is required. Moreover, cross-linking of Fas by injection of anti-Fas antibody into mice triggers induction of IP-10 and Mig in the liver. The cells providing the two signals are shown to express NK1.1 and AsGM1; elimination of these cells leads to inhibition of IFNgamma and chemokine transcript induction. The conclusion is drawn that both NK cells and T cells provide the two signals for induction of IP-10 and Mig in the liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473267     DOI: 10.1016/s0008-8749(02)00584-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  28 in total

Review 1.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

2.  Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent.

Authors:  Joshua F Heiber; Glen N Barber
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia.

Authors:  Xianying Zeng; Thomas A Moore; Michael W Newstead; Jane C Deng; Steven L Kunkel; Andrew D Luster; Theodore J Standiford
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.

Authors:  Dina M Aresvik; Torstein Øverland; Kari Lima; Rolf D Pettersen; Tore G Abrahamsen
Journal:  J Clin Immunol       Date:  2018-12-19       Impact factor: 8.317

5.  Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury.

Authors:  Denada Dibra; Jeffry Cutrera; Xueqing Xia; Bhaskar Kallakury; Lopa Mishra; Shulin Li
Journal:  Hepatology       Date:  2012-03-01       Impact factor: 17.425

Review 6.  Effector CD8 T cell trafficking within the liver.

Authors:  Luca G Guidotti; Matteo Iannacone
Journal:  Mol Immunol       Date:  2012-11-10       Impact factor: 4.407

7.  Akt/protein kinase B activation by adenovirus vectors contributes to NFkappaB-dependent CXCL10 expression.

Authors:  Qiang Liu; Lindsay R White; Sharon A Clark; Daniel J Heffner; Brent W Winston; Lee Anne Tibbles; Daniel A Muruve
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.

Authors:  Maureen N Ajuebor; Yijun Jin; Griffin L Gremillion; Robert M Strieter; Qingling Chen; Patrick A Adegboyega
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.

Authors:  Mauro Pires Moraes; Teresa de Los Santos; Marla Koster; Traci Turecek; He Wang; Vladimir G Andreyev; Marvin J Grubman
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Kathleen M Campbell; Gregg E Sabla; Alexander Miethke; Greg Tiao; Monica M McNeal; Richard L Ward; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.